Efficacy analysis of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer: a retrospective study
P-HIPEC effectively reduces the risk of postoperative PM and improves DFS in patients with locally AGC without increasing postoperative complications. However, it does not significantly impact OS. Additionally, variations in the frequency and timing of P-HIPEC initiation do not significantly affect survival outcomes, postoperative complications, or recurrence patterns.
Authors
- Qiangbang Yang
- Yingze Li (ORCID: https://orcid.org/0009-0005-9035-7218)
- Jun Zhou (ORCID: https://orcid.org/0000-0002-6059-6251)
- Xiaolu Yuan (ORCID: https://orcid.org/0009-0001-9044-5075)
- Liping Zhou (ORCID: https://orcid.org/0000-0003-2353-6134)
- Jianji Pan (ORCID: https://orcid.org/0000-0002-3211-7874)
- Zudong Huang
- Yinghao He
- Ming-Hui Ma (ORCID: https://orcid.org/0000-0002-2566-0932)
- Yanjie Deng
- Zhijie Gong (ORCID: https://orcid.org/0009-0004-9767-9423)
- Weiwei Wang (ORCID: https://orcid.org/0000-0002-3847-9956)
Institutions
- Guangdong Medical College (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3389/fonc.2024.1503045
- Citations
- 3
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 6.02